Mednet Logo

How would you approach a patient with a locoregional recurrence TNBC who requires neoadjuvant treatment?

1 Answer
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Warren Alpert Medical School of Brown University
Answered on

My assumption is that the patient developed this currently unresectable LRR after completing neoadjuvant chemotherapy and surgery, and has to be considered at high risk for both local complications, which is why you want to administer 'neoadjuvant' therapy (although I'm not sure that the term is app...

Join for free or sign in to see the full answer